The Creso Pharma [ASX:CPH] share price rose today after acquisition target Halucenex expands clinical trial recruitment.
Biotech Stocks: Investing in Cutting-Edge Healthcare Innovations
AnteoTech Shares Down after Opening Higher, Here’s Why (ASX:ADO)
It’s been a wild day of trading for AnteoTech [ASX:ADO]. After opening higher, shares began to fall just an hour after trading. With the share price currently sitting at 32 cents, down 5.8%…
Trader’s Corner — Why Do You Trade?
There is satisfaction in seeing the long-term trading stats sit around expectations. The joy is in seeing a lack of volatility in my P+L, rather than being elated when it’s rising and despairing as it falls.
Creso Pharma Share Price Dips on Halucenex Update (ASX:CPH)
The CPH share price is down 2.6%. Creso Pharma Ltd [ASX:CPH] came out of a trading halt to announce its acquisition target Halucenex has upped its psilocybin inventory…
Immutep Shares Hold Steady despite Operational Update (ASX:IMM)
Cancer immunotherapy developer Immutep Ltd [ASX:IMM] share price is trading neutral at time of writing, holding steady after flip-flopping between earlier gains and losses…
SPL Shares Up — COVID-19 Nasal Spray Launches in Europe (ASX:SPL)
As the ASX wobbles into afternoon trading, Starpharma Holdings Ltd (ASX:SPL) share price is up 2.24% at time of writing.Putting the biotech stock in the green on a day that has left many stocks in the red…
